Results 41 to 50 of about 401,873 (167)

Ibrutinib versus allogeneic haematopoietic stem cell transplant in relapsed/refractory del(17p) chronic lymphocytic leukaemia/small lymphocytic lymphoma

open access: yesBritish Journal of Haematology, Volume 209, Issue 5, Page 2284-2288, November 2026.
After adjusting for confounders, the ibrutinib cohort had significantly better overall survival (adjusted hazard ratio, 0.39; 95% confidence interval, 0.23–0.68; p = 0.0008) than the allogeneic haematopoietic stem cell transplantation (alloHSCT) cohort.
Farrukh T. Awan   +8 more
wiley   +1 more source

EXPERIÊNCIA DE UM SERVIÇO DE IMUNO-HEMATOLOGIA NA RESOLUÇÃO DE UM CASO COMPLEXO COM ANTICORPOS ANTI-HY E ANTI- JOA

open access: yesHematology, Transfusion and Cell Therapy
Introdução: Os serviços de imuno-hematologia enfrentam diariamente desafios na identificação de anticorpos irregulares, sobretudo se envolve anticorpos contra antígenos de alta frequência.
GL Oliveira   +9 more
doaj   +1 more source

Targeting the Immune System With Mesenchymal Stromal Cell-Derived Extracellular Vesicles: What Is the Cargo's Mechanism of Action?

open access: yesFrontiers in Bioengineering and Biotechnology, 2019
The potent immunomodulatory activities displayed by mesenchymal stromal cells (MSCs) have motivated their application in hundreds of clinical trials to date.
Jorge Diego Martin-Rufino   +6 more
doaj   +1 more source

Efficacy and safety of frail patients treated with ciltacabtagene autoleucel in the real world: A Center for International Blood and Marrow Transplant Research analysis

open access: yesCancer, Volume 132, Issue 19, 1 October 2026.
Abstract Background Ciltacabtagene autoleucel (cilta‐cel), an anti–B‐cell maturation antigen (BCMA) chimeric antigen receptor T‐cell (CAR‐T) therapy, is approved for relapsed/refractory multiple myeloma (RRMM). Methods Using the Center for International Blood and Marrow Transplant Research registry, this study evaluated outcomes of frail patients ...
Hira Mian   +31 more
wiley   +1 more source

The Proteome of Plasma Extracellular Vesicles in Latent and Active Tuberculosis Reveals Phase‐Specific Composition and Immunometabolic Insights

open access: yesFASEB BioAdvances, Volume 8, Issue 10, October 2026.
Plasma extracellular vesicles (EVs) from individuals with latent (LTB) or active tuberculosis (ATB) exhibit distinct proteomic compositions, reflecting the underlying immunometabolic states of each phase. In LTB, EVs are enriched in proteins associated with tissue remodeling and lipid metabolism, including TGFβ, APOA1, and APOE, which may participate ...
Eliud S.‐Peregrino   +13 more
wiley   +1 more source

El Director del Instituto de Salud Carlos III inagurará un curso sobre los últimos avances en terapia celular [PDF]

open access: yes, 2013
Nota de prensa sobre un curso sobre los últimos avances en terapia celular. El encuentro, que se celebrará del 15 al 19 de julio en Los Alcázares (Murcia), está promovido por la Red de Terapia Celular del Instituto de Salud Carlos ...
Instituto de Salud Carlos III. Gabinete de prensa
core   +1 more source

REAÇÕES ADVERSAS DURANTE COLETA DE CÉLULAS MONONUCLARES EM SERVIÇO DE HEMOTERAPIA DO RIO DE JANEIRO

open access: yesHematology, Transfusion and Cell Therapy
Objetivos: Descrever as reações adversas associadas a coletas de células mononucleares encontradas, a fim de monitorar o perfil de intercorrências no serviço de hemoterapia e planejar intervenções precoces, mitigando riscos.
DR Vidal   +6 more
doaj   +1 more source

Clinical Translation of Mesenchymal Stromal Cell Therapy for Graft Versus Host Disease

open access: yesFrontiers in Cell and Developmental Biology, 2019
Graft versus host disease (GVHD) is a common condition in patients subjected to allogeneic hematopoietic stem cell transplantation (HSCT). The immune cells derived from the grafted stem cells attack recipient’s tissues, including those from the skin ...
Juliana A. P. Godoy   +6 more
doaj   +1 more source

Terapia celular nas doenças oftalmológicas [PDF]

open access: yesRevista Brasileira de Hematologia e Hemoterapia, 2009
Avancos no campo das celulas-tronco proporcionaram muita perspectiva para uso destas celulas na regeneracao dos tecidos oculares danificados por doencas as quais nao possuem tratamento disponivel ate o momento. Terapia baseada com celulas-tronco para regeneracao e reparo ocular constitui uma esperanca para a restauracao da funcao visual em individuos ...
openaire   +3 more sources

Third Allogeneic Stem Cell Transplantation in Children: A Multicenter Analysis From the Spanish GETH‐TC Pediatric Group

open access: yesEuropean Journal of Haematology, Volume 117, Issue 4, Page 943-952, October 2026.
ABSTRACT Third allogeneic hematopoietic stem cell transplantation (HSCT3) is rarely performed in pediatric patients and is associated with high toxicity and mortality. Data on outcomes in this setting remain scarce. We conducted a retrospective multicenter study within the Spanish GETH‐TC Pediatric group including 29 children and adolescents who ...
Luisa Sisinni   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy